These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25378536)

  • 1. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
    Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
    J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
    Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
    Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
    Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
    Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
    Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
    World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Malapelle U; Mayo-de-Las-Casas C; Molina-Vila MA; Rosell R; Savic S; Bihl M; Bubendorf L; Salto-Tellez M; de Biase D; Tallini G; Hwang DH; Sholl LM; Luthra R; Weynand B; Vander Borght S; Missiaglia E; Bongiovanni M; Stieber D; Vielh P; Schmitt F; Rappa A; Barberis M; Pepe F; Pisapia P; Serra N; Vigliar E; Bellevicine C; Fassan M; Rugge M; de Andrea CE; Lozano MD; Basolo F; Fontanini G; Nikiforov YE; Kamel-Reid S; da Cunha Santos G; Nikiforova MN; Roy-Chowdhuri S; Troncone G;
    Cancer Cytopathol; 2017 Aug; 125(8):615-626. PubMed ID: 28475299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
    Harlé A; Filhine-Tresarrieu P; Husson M; Boidot R; Rouyer M; Dubois C; Leroux A; Merlin JL
    Target Oncol; 2016 Jun; 11(3):363-70. PubMed ID: 26661077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
    Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
    D'Haene N; Le Mercier M; De Nève N; Blanchard O; Delaunoy M; El Housni H; Dessars B; Heimann P; Remmelink M; Demetter P; Tejpar S; Salmon I
    PLoS One; 2015; 10(9):e0138245. PubMed ID: 26366557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Sanger and next generation sequencing performance for genotyping Cryptosporidium isolates at the 18S rRNA and actin loci.
    Paparini A; Gofton A; Yang R; White N; Bunce M; Ryan UM
    Exp Parasitol; 2015; 151-152():21-7. PubMed ID: 25662433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    Gilson P; Franczak C; Dubouis L; Husson M; Rouyer M; Demange J; Perceau M; Leroux A; Merlin JL; Harlé A
    PLoS One; 2019; 14(7):e0219204. PubMed ID: 31265477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.
    Udar N; Lofton-Day C; Dong J; Vavrek D; Jung AS; Meier K; Iyer A; Slaughter R; Gutekunst K; Bach BA; Peeters M; Douillard JY
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2001-2010. PubMed ID: 30019318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Deeb KK; Hohman CM; Risch NF; Metzger DJ; Starostik P
    Arch Pathol Lab Med; 2015 Jul; 139(7):913-21. PubMed ID: 26125431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
    Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
    Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.
    Armengol G; Sarhadi VK; Ghanbari R; Doghaei-Moghaddam M; Ansari R; Sotoudeh M; Puolakkainen P; Kokkola A; Malekzadeh R; Knuutila S
    J Mol Diagn; 2016 Jul; 18(4):471-9. PubMed ID: 27155048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.
    D'Haene N; Fontanges Q; De Nève N; Blanchard O; Melendez B; Delos M; Dehou MF; Maris C; Nagy N; Rousseau E; Vandenhove J; Gilles A; De Prez C; Verset L; Van Craynest MP; Demetter P; Van Laethem JL; Salmon I; Le Mercier M
    Oncotarget; 2018 Apr; 9(29):20761-20768. PubMed ID: 29755687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.
    Magliacane G; Grassini G; Bartocci P; Francaviglia I; Dal Cin E; Barbieri G; Arrigoni G; Pecciarini L; Doglioni C; Cangi MG
    Oncotarget; 2015 Oct; 6(31):30592-603. PubMed ID: 26435479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.
    Fujita S; Masago K; Takeshita J; Okuda C; Otsuka K; Hata A; Kaji R; Katakami N; Hirata Y
    PLoS One; 2015; 10(6):e0130219. PubMed ID: 26076009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.